...Trametinib in Pediatric Glioma with BRAF V600 Mutations...
临床试验:靶向aβ中间结构域的单克隆抗体索拉奈珠单抗(solanezumab)用于临床前阿尔茨海默病的Ⅲ期试验 DOI: 10.1056/NEJMoa2305032 ②The New England Journal of Medicine:Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations 临